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Linifanib – a multi-targeted receptor tyrosine
kinase inhibitor and a low molecular weight
gelator†
Maria Marlow,* Mohammed Al-Ameedee, Thomas Smith, Simon Wheeler and
Michael J. Stocks
In this study we demonstrate that linifanib, a multi-targeted receptor
tyrosine kinase inhibitor, with a key urea containing pharmacophore,
self-assembles into a hydrogel in the presence of low amounts of
solvent. We demonstrate the role of the urea functional group and
that of fluorine substitution on the adjacent aromatic ring in pro-
moting self-assembly. We have also shown that linifanib has superior
mechanical strength to two structurally related analogues and hence
increased potential for localisation at an injection site for drug
delivery applications.
In recent years, there has been significant interest focused on
the use of low molecular weight gelators (LMWGs) for medical
applications.1–3 Scientists working in this field are evaluating
LMWGs, which form hydrogels, for drug delivery and tissue
engineering applications4,5 and indeed there are FDA approved
molecular hydrogels for example, Lanreotide.6 To create these
hydrogels, LMWGs self-assemble into three dimensional, fibrillar
networks that have large quantities of water associated with
them.2 In the presence of low stress, these systems exhibit solid-
like behaviour even though they have a low solid content, typically
less than 2% (w/w). The properties of large amounts of associated
water and low solid content will confer biocompatibility,4 making
these systems attractive for drug delivery. One specific application
of LMWGs is cancer therapeutics, where they have been used to
localize and give controlled release of chemotherapeutics upon
intra-tumoural injection, as exemplified by Wang et al.7,8 Our
studies have extended beyond chemotherapeutics to that of
molecularly targeted drugs, such as vascular endothelial growth
factor (VEGF) inhibitors.9 We have selected one such compound –
linifanib (1, Fig. 1), a potent dual vascular endothelial growth
factor (VEGF) and platelet-derived growth factor (PDGF) tyrosine
kinase inhibitor, and was a drug candidate for the treatment of
advanced or metastatic non-small cell lung cancer, renal cancer
and pancreatic cancer.10We chose, in part, to investigate the gelation
properties of linifanib as pancreatic cancer is poorly treated by
systemic therapies due to poor drug penetration of the stromal
barrier11 and we considered that a LMWG hydrogel of such a
therapy, injected intra-tumourally, could be considered as a novel
approach to increase such poor drug penetration. This linifanib
hydrogel should confer biocompatibility to the intra-tumoural depot
due to the large amounts of associated water.4 We have also chosen
linifanib as the molecule has nanomolar potency and hence will
only require dissolution of nanomolar concentrations to achieve
efficacy.12 Another consideration in the selection of this drug was the
class of LMWGs that this drug also represents. LMWGs with a urea
moiety, which is a key part of the pharmacophore of linifanib, have
not been extensively studied for drug delivery.13 Indeed, the focus
has been on using LMWGs derived from peptides, nucleosides or
carbohydrates.14 The urea functional group is both a hydrogen bond
donor and acceptor group, known to create the one dimensional
order required for supramolecular networks.13,15 Hydrogen bonds
are formed between the oxygen atom of the carbonyl group and
hydrogen atoms of the two NH groups resulting in directional
assembly. Also hydrogen bonding contributes to drug–receptor
interactions and hence the urea functional group, with its extensive
hydrogen bonding potential has been incorporated within many
Fig. 1 Linifanib (1) and analogues (2–8) by modification of substituents on
the terminal aromatic ring adjacent to the urea.
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drug pharmacophores to give both potency and specificity. Indeed,
we speculate that there may bemany drug molecules containing the
urea functional group that are LMWGs.
We also selected linfinab due to the presence of the aromatic
rings flanking the urea functional group, leading to p–p stacking
interactions which in turn have the potential to promote self-
assembly.16 Based on our hypothesis of both the urea functional
group and the aromatic rings promoting gelation in linifanib, we
synthesized seven close analogues by modification of the substitu-
ents on the terminal aromatic ring adjacent to the urea (2–8) (Fig. 1)
and an additional analogue containing an amide group instead of
the urea group (9) (Fig. 2). The amide was chosen since it also can
provide complimentary hydrogen bonding interactions required to
promote self-assembly.2 Linifanib (1) and all eight analogues were
screened for gelation using ‘‘table top rheology’’ i.e. stable to vial
inversion.17 Gels were formed by dissolving the compounds in
DMSO, followed by adding water at 60 1C. The results of the vial
inversion screen are shown in Table 1 where the final gelator
concentration is 0.5% (w/v), which is common for a LMWG,2
in dimethyl sulfoxide (DMSO)–water mixtures from 5% (v/v) to
25% (v/v). The solvent mixture was chosen as linifanib is soluble
in DMSO but insoluble in water at the required concentration;
there is significant literature precedent for using this anti-solvent
approach;18,19 and increased concentrations of DMSO are potentially
advantageous in cancer where DMSO has been shown to reduce the
tumourigenicity of human pancreatic cell lines.20 Using water as the
anti-solvent we were able to reproducibly induce gelation for linifa-
nib (1) and the synthesised analogues that contained a fluorine atom
substituted on the aromatic ring and the urea functional group in
the structure (2, 3 and 4). The gels that formed were stable to vial
inversion (Fig. 3). Moreover, the role of the urea functional group to
promote gelation was demonstrated by comparison of the gelation
behavior of 3 and 9. This structural change from urea (gel) to amide
(precipitate) in the vial inversion screen demonstrated the important
role that the urea functional group plays in the gelation of linifanib
and its structural analogues. However, the 2-methoxy analogue (5)
and the un-substituted terminal aromatic ring analogue (6), formed
precipitates under all the conditions and likewise both the 2-chloro
analogue (7) and the nitrile analogue (8) failed to gel, even though
they both had electron-withdrawing substituents on the terminal
aromatic ring. These observations are not surprising given the
previously reported data of Nilsson et al.,16 who showed that
minor substitutions on the aromatic ring of Fmoc-protected
aromatic amino acids influenced gelation. They demonstrated
the effect was a result of both steric and electronic changes in
p–p stacking interactions.
Specifically, they describe how a fluorine atom substituted on a
toluene ring (also present in the terminal aromatic ring of linifanib)
can create a more electron deficient aromatic ring as compared to
substitution with other halogens and also fluorine has a beneficial
smaller molecular volume. Also described in the Nilsson paper is
that the halogen identity and position of substitution on the ring
influences the gel strength. We also found in our studies that
linifanib (1), with an ortho substituted fluorine, gave stronger gels
as compared to its fluorine substituted analogues (2, 3 (di-fluoro
substituted) and 4 (meta substituted fluorine)) respectively in the vial
inversion screen and confirmed by rheology for analogue 3 (see S3,
ESI†). Linifanib was selected as the focus for further physical
characterization dues it greater mechanical strength as this is an
important attribute for a drug delivery applications where mecha-
nical strength can influence localization at an injection site.21,22
Firstly, further vial inversion screening for gelation was carried
out with a series of binary mixtures of DMSO and water (Table 2).
These results indicate that DMSO:water ratio had a significant eﬀect
on gelation which has also been observed for other LMWGs.18,23 The
linifanib gels that were most stable to vial inversion were obtained
with 5% (v/v) DMSO–water. Interestingly, there seems to be an
optimum ratio of linifanib to DMSO in that too much DMSO
disrupts the hydrogen bonding interactions. Hence, at a low
solvent ratio (5% (v/v)), we confirmed the fibrillar structure of
the linifanib gels by the transmission electron microscopy (TEM).
0.5% (w/v) linifanib, demonstrated a branched pattern of fibres
100 to 300 nm in width and 4.5 to 9 microns in length (Fig. 3).
Table 1 Vial inversion screen of 0.5% (w/v) linifanib and linifanib analogues
in DMSO–water mixtures, where a gel (G), or a precipitate (P) was formed
Compound v/v DMSO–water 1 2 3 4 5 6 7 8 9
5 G G G G P P P P P
10 G G G G P P P P P
15 G P G G P P P P P
20 P P G P P P P P P
25 P P G P P P P P P
Fig. 2 Analogue (9) by replacement of the urea functional group by an amide.
Fig. 3 (a) Vial inversion screen of linifanib and its fluorinated analogues
(left to right: linifanib (1) and linifanib analogues 2, 3 and 4) (b) transmission
electron micrograph (TEM): 0.5% (w/v) linifanib in 5% (v/v) DMSO–water;
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Having confirmed the characteristic LMWG fibrillar network,
we then undertook oscillatory rheology experiments with linifanib
concentrations from 0.0625 to 1.25% (w/v) in 5% (v/v) DMSO–
water. The measurements were performed at strains of 0.01% to
100% strain at 10 rad s1 and the storage modulus (G0) and loss
modulus (G00) are reported from within the linear viscoelastic
region (Fig. 4). These experiments provided key evidence of
gelation of linifanib in DMSO–water as demonstrated by the G0
exceeding G00 by at least an order of magnitude proving the
viscoelastic nature of the gel.24 Additionally, a sustained linear
viscoelastic region was found between 0.01–1% (see S3, ESI†). Our
G0 data (1.5  104 Pa) is lower than the gels (106 Pa) as reported
Kleinsmann25 and Yu,24 but greater than the G0 100 Pa of gels as
reported by Ren26 for a Gemcitabine LMWG. An increase in the
moduli with increasing concentration of linifanib was also
observed which has likewise been shown for other LMWGs, for
example the simple chiral bisureas of Rodriguez-Llansola et al.27
Additionally, in a similar manner to Adams et al.,28 we evaluated
the power law relationship between G0 and gelator concentration
i.e. G0 p Cx (see S3, ESI†, Fig. 3). We found that x was 1.86
indicative of a semi-entangled network.
In summary, we have demonstrated that the multi-targeted
receptor tyrosine kinase inhibitor, linifanib, with a urea contain-
ing pharmacophore, is a LMWG and forms a hydrogel in low
solvent ratios of DMSO–water. Representative gels were studied
using rheology and TEM and their fibrillar structure confirmed.
Through the synthesis of structurally related analogues we have
also shown the importance of both the urea functional group and
position of the essential fluorine substitution on the terminal
aromatic ring in promoting gelation. We also shown that linifanib
has superior mechanical strength its structurally related analo-
gues and hence increased potential for localisation at an injection
site for drug delivery applications.
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